ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687522 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687522; 2) Community: the network communities that were significantly associated with the response to NSC 687522; 3) Molecule: the relationships between components within communities and NSC 687522; 4) MDR: the compounds that were significantly associated with the NSC 687522.

NSC Compound Enrichment Correlation
NSC 665514 Null 0.0385613993886001 -0.17753129
NSC 666126 Null 0.0385613993886001 -0.14850793
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.0385613993886001 -0.10287765
NSC 670408 Null 0.0385613993886001 -0.32108301
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.0385613993886001 -0.04870795
NSC 673464 Null 0.0385613993886001 -0.19581118
NSC 673652 2-Ethylaminoestradiol 0.0385613993886001 -0.21661469
NSC 676830 Null 0.0385613993886001 0.019083161
NSC 681632 Camptothecin Derivative 0.0385613993886001 -0.098876534
NSC 681633 Camptothecin Derivative 0.0385613993886001 -0.038544507
Total:83  Current:58    [First] [Prev] [Next] [Last]